MedPath

pentobarbital sodium

Pentobarbital Sodium Injection, USP VialsDO NOT USE IF MATERIAL HAS PRECIPITATED

Approved
Approval ID

e9f4b344-b092-4eec-b49d-d8cfe8ebc05d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 30, 2017

Manufacturers
FDA

Sagent Pharmaceuticals

DUNS: 796852890

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

pentobarbital sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code25021-676
Application NumberANDA206404
Product Classification
M
Marketing Category
C73584
G
Generic Name
pentobarbital sodium
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateApril 18, 2017
FDA Product Classification

INGREDIENTS (6)

waterInactive
Code: 059QF0KO0R
Classification: IACT
pentobarbital sodiumActive
Quantity: 50 mg in 1 mL
Code: NJJ0475N0S
Classification: ACTIB
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
alcoholInactive
Code: 3K9958V90M
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT

Drug Labeling Information

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 6/30/2017

CII
SAGENT®
Rx only

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.